Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Science"
DOI: 10.1111/cts.13297
Abstract: During the latest pandemic, the RECOVERY study showed the benefits of dexamethasone (DEX) use in COVID‐19 patients. Obesity has been proven to be an independent risk factor for severe forms of infection, but little information… read more here.
Keywords: observational exploratory; covid patients; weight obese; dex ... See more keywords